No Clinically Significant Drug Resistance Mutations In HIV-1 subtype C Infected Women After Discontinuation Of NRTI-Based Or PI-Based HAART For PMTCT In Botswana

Risk of developing drug resistance after stopping antiretroviral regimens to prevent mother-to-child HIV-1 transmission (PMTCT) is unknown. Mma Bana Study randomized treatment-naïve pregnant women with CD4 ≥200 cells/mm(3) to receive either abacavir/zidovudine/lamivudine (triple NRTI arm) or lopinav...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Souda, Sajini, Gaseitsiwe, Simani, Georgette, Nathan, Powis, Kathleen, Moremedi, Daisy, Iketleng, Thato, Leidner, Jean, Moffat, Claire, Ogwu, Anthony, Lockman, Shahin, Moyo, Sikhulile, Mmalane, Mompati, Musonda, Rosemary, Makhema, Joseph, Essex, Max, Shapiro, Roger
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3762949/
https://ncbi.nlm.nih.gov/pubmed/23542639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31829308f8
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים